" class="no-js "lang="en-US"> Peter Johnson - Medtech Alert
Friday, April 18, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Peter Johnson

Peter Johnson

About Peter Johnson

Related Story

Diseases

 NHS To Roll Out Life-Extending Drug For Advanced Gastroesophageal Cancer | PTF

NHS To Roll Out Life-Extending Drug For Advanced Gastroesophageal Cancer

November 24 2022

NHS comments on NICE decision to approve Nivolumab to treat rare forms of gastroesophageal cancer […]

Diseases

 Breakthrough Treatment to Boost Life Chances for Hundreds of People With Respiratory Cancer | Pharmtech Focus

Breakthrough Treatment to Boost Life Chances for Hundreds of People With Respiratory Cancer

July 18 2022

The first new mesothelioma treatment to be approved in nearly 15 years will be made […]

Diseases

 Hundreds of Patients to Benefit From Revolutionary Lung Cancer Drug On The NHS | Pharmtech Focus

Hundreds of Patients to Benefit From Revolutionary Lung Cancer Drug On The NHS

March 3 2022

A revolutionary targeted drug for lung cancer will be made available to anyone who is […]

Diseases

 ‘Skin Snaps’ and Rapid Tests Among £20 Million NHS Push to Speed Cancer Diagnosis | Pharmtech Focus

‘Skin Snaps’ and Rapid Tests Among £20 Million NHS Push to Speed Cancer Diagnosis

July 13 2021

‘Skin snaps’ and rapid tests for same day diagnosis are among a package of measures […]